BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

639 related articles for article (PubMed ID: 27001965)

  • 1. Treatment Effect of Clopidogrel Plus Aspirin Within 12 Hours of Acute Minor Stroke or Transient Ischemic Attack.
    Li Z; Wang Y; Zhao X; Liu L; Wang D; Wang C; Meng X; Li H; Pan Y; Wang X; Wang C; Yang X; Zhang C; Jing J; Xian Y; Johnston SC; Wang Y;
    J Am Heart Assoc; 2016 Mar; 5(3):e003038. PubMed ID: 27001965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homocysteine Level Predicts Response to Dual Antiplatelet in Women With Minor Stroke or Transient Ischemic Attack: Subanalysis of the CHANCE Trial.
    Li J; Wang Y; Li H; Zuo Z; Lin J; Wang A; Zhao X; Liu L; Wang Y;
    Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):839-846. PubMed ID: 31941381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Estimated Glomerular Filtration Rate Decline on the Efficacy and Safety of Clopidogrel With Aspirin in Minor Stroke or Transient Ischemic Attack: CHANCE Substudy (Clopidogrel in High-Risk Patients With Acute Nondisabling Cerebrovascular Events).
    Zhou Y; Pan Y; Wu Y; Zhao X; Li H; Wang D; Johnston SC; Liu L; Wang C; Meng X; Wang Y; Wang Y;
    Stroke; 2016 Nov; 47(11):2791-2796. PubMed ID: 27738237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA.
    Johnston SC; Easton JD; Farrant M; Barsan W; Conwit RA; Elm JJ; Kim AS; Lindblad AS; Palesch YY;
    N Engl J Med; 2018 Jul; 379(3):215-225. PubMed ID: 29766750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack.
    Wang Y; Wang Y; Zhao X; Liu L; Wang D; Wang C; Wang C; Li H; Meng X; Cui L; Jia J; Dong Q; Xu A; Zeng J; Li Y; Wang Z; Xia H; Johnston SC;
    N Engl J Med; 2013 Jul; 369(1):11-9. PubMed ID: 23803136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clopidogrel With Aspirin in Acute Minor Stroke or Transient Ischemic Attack (CHANCE) Trial: One-Year Outcomes.
    Wang Y; Pan Y; Zhao X; Li H; Wang D; Johnston SC; Liu L; Meng X; Wang A; Wang C; Wang Y;
    Circulation; 2015 Jul; 132(1):40-6. PubMed ID: 25957224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual Antiplatelet Therapy in Transient Ischemic Attack and Minor Stroke With Different Infarction Patterns: Subgroup Analysis of the CHANCE Randomized Clinical Trial.
    Jing J; Meng X; Zhao X; Liu L; Wang A; Pan Y; Li H; Wang D; Johnston SC; Wang Y; Wang Y
    JAMA Neurol; 2018 Jun; 75(6):711-719. PubMed ID: 29582084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors associated with 90-day recurrent stroke in patients on dual antiplatelet therapy for minor stroke or high-risk TIA: a subgroup analysis of the CHANCE trial.
    Wangqin R; Wang X; Wang Y; Xian Y; Zhao X; Liu L; Li H; Meng X; Wang Y
    Stroke Vasc Neurol; 2017 Dec; 2(4):176-183. PubMed ID: 29507777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clopidogrel and aspirin after ischemic stroke or transient ischemic attack: an updated systematic review and meta-analysis of randomized clinical trials.
    Kheiri B; Osman M; Abdalla A; Haykal T; Swaid B; Ahmed S; Chahine A; Hassan M; Bachuwa G; Al Qasmi M; Bhatt DL
    J Thromb Thrombolysis; 2019 Feb; 47(2):233-247. PubMed ID: 30511260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between CYP2C19 Loss-of-Function Allele Status and Efficacy of Clopidogrel for Risk Reduction Among Patients With Minor Stroke or Transient Ischemic Attack.
    Wang Y; Zhao X; Lin J; Li H; Johnston SC; Lin Y; Pan Y; Liu L; Wang D; Wang C; Meng X; Xu J; Wang Y;
    JAMA; 2016 Jul; 316(1):70-8. PubMed ID: 27348249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk for Major Hemorrhages in Patients Receiving Clopidogrel and Aspirin Compared With Aspirin Alone After Transient Ischemic Attack or Minor Ischemic Stroke: A Secondary Analysis of the POINT Randomized Clinical Trial.
    Tillman H; Johnston SC; Farrant M; Barsan W; Elm JJ; Kim AS; Lindblad AS; Palesch YY; Easton JD
    JAMA Neurol; 2019 Jul; 76(7):774-782. PubMed ID: 31034032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time Course for Benefit and Risk of Clopidogrel and Aspirin After Acute Transient Ischemic Attack and Minor Ischemic Stroke.
    Johnston SC; Elm JJ; Easton JD; Farrant M; Barsan WG; Kim AS; Lindblad AS; Palesch YY; Zurita KG; Albers GW; Cucchiara BL; Kleindorfer DO; Lutsep HL; Pearson C; Sethi P; Vora N;
    Circulation; 2019 Aug; 140(8):658-664. PubMed ID: 31238700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Glycemic Control on Efficacy of Clopidogrel in Transient Ischemic Attack or Minor Stroke Patients With
    Lin Y; Wang A; Li J; Lin J; Wang D; Meng X; Ou L; Chen W; Zhao X; Liu L; Wang Y; Wang Y;
    Stroke; 2017 Apr; 48(4):998-1004. PubMed ID: 28289237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycated albumin predicts the effect of dual and single antiplatelet therapy on recurrent stroke.
    Li J; Wang Y; Wang D; Lin J; Wang A; Zhao X; Liu L; Wang C; Wang Y;
    Neurology; 2015 Mar; 84(13):1330-6. PubMed ID: 25740863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effectiveness and safety of dual antiplatelet therapy in ischemic cerebrovascular disease with intracranial and extracranial arteriostenosis in Chinese patients: A randomized and controlled trail.
    Zuo FT; Liu H; Wu HJ; Su N; Liu JQ; Dong AQ
    Medicine (Baltimore); 2017 Jan; 96(1):e5497. PubMed ID: 28072691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual antiplatelet therapy in stroke and ICAS: Subgroup analysis of CHANCE.
    Liu L; Wong KS; Leng X; Pu Y; Wang Y; Jing J; Zou X; Pan Y; Wang A; Meng X; Wang C; Zhao X; Soo Y; Johnston SC; Wang Y;
    Neurology; 2015 Sep; 85(13):1154-62. PubMed ID: 26330567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes Associated With Clopidogrel-Aspirin Use in Minor Stroke or Transient Ischemic Attack: A Pooled Analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trials.
    Pan Y; Elm JJ; Li H; Easton JD; Wang Y; Farrant M; Meng X; Kim AS; Zhao X; Meurer WJ; Liu L; Dietrich D; Wang Y; Johnston SC
    JAMA Neurol; 2019 Dec; 76(12):1466-1473. PubMed ID: 31424481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The association of lipid profile and bleeding in patients with minor stroke or transient ischemic attack on antiplatelet therapy: subgroup analysis of CHANCE].
    Li JJ; Gu HQ; Peng YJ; Zhao XQ; Wang YL; Meng X; Liu LP; Wang YJ
    Zhonghua Nei Ke Za Zhi; 2018 Oct; 57(10):723-730. PubMed ID: 30293332
    [No Abstract]   [Full Text] [Related]  

  • 19. Initial 3-weeks' Apixaban Versus Dual-antiplatelet Therapy (Clopidogrel and Aspirin) followed by Clopidogrel alone in high-risk patients with Acute Non-Disabling Cerebrovascular Events (ADANCE): study protocol for a randomized controlled trial.
    Yang F; Lei H; Jiang W; Jiang W; Han J; Zhao G
    Clin Drug Investig; 2014 Nov; 34(11):755-61. PubMed ID: 25200142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual Antiplatelet Treatment up to 72 Hours after Ischemic Stroke.
    Gao Y; Chen W; Pan Y; Jing J; Wang C; Johnston SC; Amarenco P; Bath PM; Jiang L; Yang Y; Wang T; Han S; Meng X; Lin J; Zhao X; Liu L; Zhao J; Li Y; Zang Y; Zhang S; Yang H; Yang J; Wang Y; Li D; Wang Y; Liu D; Kang G; Wang Y; Wang Y;
    N Engl J Med; 2023 Dec; 389(26):2413-2424. PubMed ID: 38157499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.